Lexaria Bioscience Corp.

NASDAQ: LEXX · Real-Time Price · USD
0.83
0.01 (1.28%)
At close: Aug 18, 2025, 3:59 PM
0.82
-1.60%
After-hours: Aug 18, 2025, 06:37 PM EDT

Lexaria Bioscience Cash Flow Statement

Financials in USD. Fiscal year is September - August.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Aug 31, 2024 Aug 31, 2023 Aug 31, 2022 Aug 31, 2021
Net Income
-5.81M -6.71M -7.38M -4.19M
Depreciation & Amortization
76.15K 145.4K 141.31K 147.6K
Stock-Based Compensation
492.24K 170.38K 752.59K 410.01K
Other Working Capital
-684.36K -14.84K -262.73K -234.89K
Other Non-Cash Items
174.71K 530.35K 1.96M 92.91K
Deferred Income Tax
n/a -158.1K n/a -517.57K
Change in Working Capital
106.56K 143.26K -351.48K 63.53K
Operating Cash Flow
-4.96M -5.88M -4.88M -3.99M
Capital Expenditures
-43.02K -169.61K -131.45K -79.49K
Cash Acquisitions
n/a n/a n/a 273.37K
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-188.6K -135.86K -49.19K 273.37K
Investing Cash Flow
-188.6K -169.61K -180.64K 193.88K
Debt Repayment
n/a n/a n/a -66.69K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
6.11M n/a -44.6K 4.02M
Financial Cash Flow
10.32M 1.59M -44.6K 13.42M
Net Cash Flow
5.15M -4.46M -5.1M 9.62M
Free Cash Flow
-5M -6.05M -5.01M -4.07M